Holen Sie sich die Stockscreener-App
1.56
3.11%
-0.05
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 (NASDAQ:INO) - Seeking Alpha
Will Inovio Pharmaceuticals Inc. (GBM) stock announce special dividend2025 Investor Takeaways & Low Risk Growth Stock Ideas - ulpravda.ru
Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Why retail investors pile into Inovio Pharmaceuticals Inc. stockJuly 2025 Decliners & Real-Time Buy Zone Alerts - ulpravda.ru
Retail Trends: Will Inovio Pharmaceuticals Inc. (GBM) stock announce special dividendMarket Performance Recap & Daily Price Action Insights - ulpravda.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc.INO - PR Newswire
AstraZeneca pullback hits Inovio shares - The Pharma Letter
Looking Into Inovio Pharmaceuticals Inc's Recent Short Interest - Sahm
INOVIO announces pricing of $25M public offering - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio ... - Bluefield Daily Telegraph
Upcoming Events - FinancialContent
Inovio Pharmaceuticals Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - Early Times
Ksolves India Limited Bounces Off Moving Average SupportStock Correlation Metrics & Superior Return Stocks - earlytimes.in
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
FDA sets 2026 decision clock for INOVIO’s rare disease therapy - MSN
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance - MyChesCo
INOVIO Reports Inducement Grant Under Inducement Plan - Eastern Progress
RSI Check: Will Inovio Pharmaceuticals Inc GBM stock announce special dividendEarnings Recap Summary & Free Verified High Yield Trade Plans - moha.gov.vn
FDA Sets 2026 Decision Clock for INOVIO’s Rare Disease Therapy - MyChesCo
Inovio respiratory DNA drug candidate shows promise in early trial - MSN
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Inovio drops as respiratory papillomatosis asset denied accelerated review - MSN
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Jefferies reiterates Hold on Inovio stock amid FDA review uncertainty By Investing.com - Investing.com Canada
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - FinancialContent
Inovio stock plummets 25% after FDA denies accelerated review for lead drug candidate - The Business Journals
INOVIO’s DNA therapy for rare throat disease gets FDA review - Indian Pharma Post
Inovio Pharmaceuticals stock steady as FDA accepts BLA for INO-3107 - Investing.com Canada
Boston Herald - FinancialContent
FDA accepts Inovio’s BLA for INO-3107 review - MSN
FDA setback gives Inovio a headache - The Pharma Letter
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why Is Inovio Pharma Stock Sinking Monday?Inovio Pharmaceuticals (NASDAQ:INO) - Benzinga
Inovio (INO) Shares Plummet 21% After FDA Review Update - GuruFocus
Inovio stock tumbles after FDA questions accelerated approval path By Investing.com - Investing.com Australia
Inovio stock tumbles after FDA questions accelerated approval path - Investing.com India
Inovio Pharmaceuticals Inc: Not Currently Pla - 富途牛牛
EBIT per share of Inovio Pharmaceuticals, Inc. – BIVA:INO - TradingView — Track All Markets
INOVIO (INO) Seeks Accelerated Approval for INO-3107 from FDA - GuruFocus
INOVIO Pharmaceuticals, Inc. Announces FDA Acceptance of BLA for INO-3107 - TradingView — Track All Markets
FDA accepts INOVIO’s BLA for RRP treatment, sets October 2026 target date - Investing.com UK
Rare throat disease may get a new non-surgical treatment option - Stock Titan
Inovio Stock Sinks As FDA Pushes Back On Accelerated Approval For Rare Disease Drug - Sahm
INOVIO Issues Equity Award to New Hire as It Rebuilds for Its Next Act - MyChesCo
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
INO (Inovio Pharmaceuticals) EV-to-OCF : -1.30 (As of Dec. 22, 2025) - GuruFocus
Sentiment Review: Is AMODW stock attractive for long term wealth buildingGap Down & Expert Approved Momentum Ideas - moha.gov.vn
Published on: 2025-12-22 07:17:12 - moha.gov.vn
INOVIO Advances Toward First Commercial Product as BLA Filing Caps Pivotal Quarter - MSN
Published on: 2025-12-21 00:43:45 - Улправда
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):